Pular para o conteúdo principal
Ranking Invest

QDEL - QuidelOrtho Corporation

Segmento: HealthcareQuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

Análise Ranking Invest

Valuation estimado
-17,90%
-$ 1.35 Bi
Valor de Mercado
$ 808.50 Mi
Desconto (AV)-159.9%
IVR
-1.67A companhia vale -1,67 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-3.79O valuation alternativo equivale a -379% do valor de mercado da companhia.
MLL
-3.79O lucro líquido dos controladores em 16 trimestres equivale a -379% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 1.77 Bi

Dívida Líquida

$ 588.00 Mi

L4T

-$ 1.05 Bi

MM4T

-38.08%

Indicadores Básicos

ROE

-59.07%

Índices de Previsibilidade

Receita Líquida

C0.05

Lucro

F3.94

Margem

E1.41

Índices de Tendência

Receita Líquida

F-8.58

Lucro

F-6.25

Margem

F-6.32

Índices de Endividamento

DIV/PAT

0.33

DIV/L4T

-0.56

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.